Skip to main content
Log in

Vitamin K antagonists in children with central venous catheter on chronic haemodialysis: a pilot study

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Background

To date, no study has investigated the use of vitamin K antagonists (VKA) in children undergoing chronic haemodialysis (HD) with a central venous catheter (CVC).

Methods

Consecutive patients aged <18 years with a newly placed tunnelled CVC for chronic HD were enrolled over a 3-year period. Children with active nephrotic syndrome or a history of venous thrombosis received warfarin (VKA group) with therapeutic target international normalised ratios of between 2.0 and 3.0. Patients at standard risk of CVC malfunction were not treated with VKA (standard group). The primary end-point was overall CVC survival.

Results

The VKA group consisted of nine patients (median age 10.6 years; range 1.2–15.3 years) with 11 CVC, and the standard group comprised eight patients (11.8 years; 6.1–17.3 years) with ten CVC. The 6- and 12-month CVC survival was significantly longer in the VKA group than in the standard group (100 vs. 60 % and 83.3 vs. 16.7 %, respectively; p < 0.05), with a median survival of 369 and 195 days, respectively (p < 0.05). None of the CVC in the VKA group required removal due to malfunction, as compared to four in the standard group. No major bleeding episodes occurred in either group.

Conclusions

Therapy with VKA would appear to be safe in children on chronic HD and may improve CVC survival in patients at increased risk of CVC thrombosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Chand DH, Valentini RP, Kamil ES (2009) Hemodialysis vascular access options in pediatrics: considerations for patients and practitioners. Pediatr Nephrol 24:1121–1128

    Article  PubMed  PubMed Central  Google Scholar 

  2. Ramage IJ, Bailie A, Tyerman KS, McColl JH, Pollard SG, Fitzpatrick MM (2005) Vascular access survival in children and young adults receiving long-term hemodialysis. Am J Kidney Dis 45:708–714

    Article  PubMed  Google Scholar 

  3. Chand DH, Brier M, Strife CF (2005) Comparison of vascular access type in pediatric hemodialysis patients with respect to urea clearance, anemia management, and serum albumin concentration. Am J Kidney Dis 45:303–308

    Article  PubMed  Google Scholar 

  4. Zaritsky JJ, Salusky IB, Gales B, Ramos G, Atkinson J, Allsteadt A, Brandt ML, Goldstein SL (2008) Vascular access complications in long-term pediatric hemodialysis patients. Pediatr Nephrol 23:2061–2065

    Article  PubMed  Google Scholar 

  5. Paglialonga F, Rossetti G, Giannini A, Chidini G, Napolitano L, Testa S, Meregalli E, Biasuzzi A, Edefonti A (2012) Split catheters in children on chronic hemodialysis: a single-center experience. Hemodial Int 16:394–400

    Article  PubMed  Google Scholar 

  6. National Kidney Foundation (NKF) (2006) KDOQI clinical practice guidelines and clinical practice recommendations for 2006 updates: hemodialysis adequacy, peritoneal dialysis adequacy, vascular access. Am J Kidney Dis 48[Suppl 1]:S1–S322

  7. Chand DH, Valentini RP (2008) International pediatric fistula first initiative: a call to action. Am J Kidney Dis 51:1016–1024

    Article  PubMed  Google Scholar 

  8. Fadrowski JJ, Hwang W, Neu AM, Fivush BA, Furth SL (2009) Patterns of use of vascular catheters for hemodialysis in children in the United States. Am J Kidney Dis 53:91–98

    Article  PubMed  PubMed Central  Google Scholar 

  9. Valentini RP, Geary DF, Chand DH (2008) Central venous lines for chronic hemodialysis: survey of the Midwest pediatric nephrology consortium. Pediatr Nephrol 23:291–295

    Article  PubMed  Google Scholar 

  10. Neu AM, Ho PL, McDonald RA, Warady BA (2002) Chronic dialysis in children and adolescents. The 2001 NAPRTCS annual report. Pediatr Nephrol 17:656–663

    Article  PubMed  Google Scholar 

  11. Leonard MB, Donaldson LA, Ho M, Geary DF (2003) A prospective cohort study of incident maintenance dialysis in children: an NAPRTCS study. Kidney Int 63:744–755

    Article  PubMed  Google Scholar 

  12. Neu AM, Fivush BA, Warady BA, Watkins SL, Friedman AL, Brem AS, Goldstein S, Frankenfield DL (2003) Longitudinal analysis of intermediate outcomes in adolescent hemodialysis patients. Pediatr Nephrol 18:1172–1176

    Article  PubMed  Google Scholar 

  13. Hayes WN, Watson AR, Callaghan N, Wright E, Stefanidis CJ, the European Pediatric Dialysis Working Group (2012) Vascular access: choice and complications in European paediatric haemodialysis units. Pediatr Nephrol 27:999–1004

    Article  PubMed  Google Scholar 

  14. Wang AY, Ivany JN, Perkovich V, Gallagher MP, Jardine MJ (2013) Anticoagulant therapies for the prevention of intravascular catheters malfunction in patients undergoing haemodialysis: systematic review and meta-analysis of randomized, controlled trials. Nephrol Dial Transplant 28:2875–2888

    Article  CAS  PubMed  Google Scholar 

  15. Mokrzycki MH, Jean-Jerome K, Rush H, Zdunek MP, Rosenberg SO (2001) A randomized trial of minidose warfarin for the prevention of late malfunction in tunneled, cuffed hemodialysis catheters. Kidney Int 59:1935–1942

    Article  CAS  PubMed  Google Scholar 

  16. Traynor JP, Walbaum D, Woo YM, Teenan P, Fox JG, Mactier RA (2001) Low-dose warfarin fails to prolong survival of dual lumen venous dialysis catheters. Nephrol Dial Transplant 16:645

    Article  CAS  PubMed  Google Scholar 

  17. Wilkieson TJ, Ingram AJ, Crowther MA, Soroka SD, Nagai R, Jindal KK, Clase CM (2011) Low-intensity adjusted-dose warfarin for the prevention of hemodialysis catheter failure: a randomized, controlled trial. Clin J Am Soc Nephrol 6:1018–1024

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Abdul-Rahman IS, Al-Howaish AK (2007) Warfarin versus aspirin in preventing tunneled hemodialysis catheter thrombosis: a prospective randomized study. Hong Kong J Nephrol 9:23–30

    Article  CAS  Google Scholar 

  19. Coli L, Donati G, Cianciolo G, Raimondi C, Comai G, Panicali L, Nastasi V, Cannarile DC, Gozzetti F, Piccari M, Stefoni S (2006) Anticoagulation therapy for the prevention of hemodialysis tunneled cuffed catheters (TCC) thrombosis. J Vasc Access 7:118–122

    CAS  PubMed  Google Scholar 

  20. Christiansen CF, Schmidt M, Lamberg AL, Horváth-Puhó E, Baron JA, Jespersen B, Sørensen HT (2014) Kidney disease and risk of venous thromboembolism: a nationwide population-based case–control study. J Thromb Haemost 12:1449–1454

    Article  CAS  PubMed  Google Scholar 

  21. Tavil B, Kara F, Topaloglu R, Aytac S, Unal S, Kuskonmaz B, Cetin M, Besbas N, Gumruk F (2015) Case series of thromboembolic complications in childhood nephrotic syndrome: Hacettepe experience. Clin Exp Nephrol 19:506–513

    Article  PubMed  Google Scholar 

  22. Singhal R, Brimble KS (2006) Thromboembolic complications in the nephrotic syndrome: pathophysiology and clinical management. Thromb Res 118:397–407

    Article  CAS  PubMed  Google Scholar 

  23. Glassock RJ (2007) Prophylactic anticoagulation in nephrotic syndrome: a clinical conundrum. J Am Soc Nephrol 18:2221–2225

    Article  PubMed  Google Scholar 

  24. Suri D, Ahluwalia J, Saxena AK, Sodhi KS, Singh P, Mittal BR, Das R, Rawat A, Singh S (2014) Thromboembolic complications in childhood nephrotic syndrome: a clinical profile. Clin Exp Nephrol 18:803–881

    Article  PubMed  Google Scholar 

  25. Barbano B, Gigante A, Amoroso A, Cianci R (2013) Thrombosis in nephrotic syndrome. Semin Thromb Hemost 39:469–476

    Article  CAS  PubMed  Google Scholar 

  26. Pincus KJ, Hynicka LM (2013) Prophylaxis of thromboembolic events in patients with nephrotic syndrome. Ann Pharmacother 47:725–734

    Article  PubMed  Google Scholar 

  27. Kerlin BA, Ayoob R, Smoyer WE (2012) Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease. Clin J Am Soc Nephrol 7:513–520

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Wright JM, Watts RG (2011) Venous thromboembolism in pediatric patients: epidemiologic data from a pediatric tertiary care center in Alabama. J Pediatr Hematol Oncol 33:261–264

    Article  PubMed  Google Scholar 

  29. MacRae JM, Ahmed A, Johnson N, Levin A, Kiaii M (2005) Central vein stenosis: a common problem in patients on hemodialysis. ASAIO J 51:77–81

    Article  PubMed  Google Scholar 

  30. Schulman S, Kearon C, Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis (2005) Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 3:692–694

    Article  CAS  PubMed  Google Scholar 

  31. Kovalski Y, Cleper R, Krause I, Davidovits M (2007) Hemodialysis in children weighing less than 15 kg: a single center experience. Pediatr Nephrol 22:2105–2110

    Article  PubMed  Google Scholar 

  32. Schillinger F, Schillinger D, Montagnac R, Milcent T (1991) Post catheterization vein stenosis in haemodialysis: comparative angiographic study of 50 subclavian and 50 internal jugular accesses. Nephrol Dial Transplant 6:722–724

    Article  CAS  PubMed  Google Scholar 

  33. Hernández D, Díaz F, Rufino M, Lorenzo V, Pérez T, Rodríguez A, De Bonis E, Losada M, González-Posada JM, Torres A (1998) Subclavian vascular access stenosis in dialysis patients: natural history and risk factors. J Am Soc Nephrol 9:1507–1510

    PubMed  Google Scholar 

  34. Yevzlin AS (2008) Hemodialysis catheter-associated central venous stenosis. Semin Dial 21:522–527

    Article  PubMed  Google Scholar 

  35. Goldstein SL, Macierowski CT, Jabs K (1997) Hemodialysis catheter survival and complications in children and adolescents. Pediatr Nephrol 11:74–77

    Article  CAS  PubMed  Google Scholar 

  36. Sheth RD, Kale AS, Brewer ED, Brandt ML, Nuchtern JG, Goldstein SL (2001) Successful use of Tesio catheters in pediatric patients receiving chronic hemodialysis. Am J Kidney Dis 38:553–559

    Article  CAS  PubMed  Google Scholar 

  37. Eisenstein I, Tarabeih M, Magen D, Pollack S, Kassis I, Ofer A, Engel A, Zelikovic I (2011) Low infection rates and prolonged survival times of hemodialysis catheters in infants and children. Clin J Am Soc Nephrol 6:793–798

    Article  PubMed  PubMed Central  Google Scholar 

  38. Silverstein DM, Moylan K (2010) Cause and outcome of central venous catheter infections in paediatric haemodialysis patients. Nephrol Dial Transplant 25:3332–3337

    Article  PubMed  Google Scholar 

  39. Yee DL, O'Brien SH, Young G (2013) Pharmacokinetics and pharmacodynamics of anticoagulants in paediatric patients. Clin Pharmacokinet 52:967–980

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Fabio Paglialonga.

Ethics declarations

Ethics statement

The study was approved by the local Ethical Committee and conforms with the Declaration of Helsinki. All parents gave written informed consent

Conflict of interest

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Paglialonga, F., Artoni, A., Braham, S. et al. Vitamin K antagonists in children with central venous catheter on chronic haemodialysis: a pilot study. Pediatr Nephrol 31, 827–832 (2016). https://doi.org/10.1007/s00467-015-3293-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-015-3293-1

Keywords

Navigation